AIBT Stock Chart & Stats
<$0.01
>-$0.01(-25.00%)
At close: 4:00 PM EDT
<$0.01
>-$0.01(-25.00%)
Day’s Range― - ―
52-Week Range<$0.01 - $0.14
Previous CloseN/A
Volume1.10M
Average Volume (3M)164.00K
Market Cap
$1.87M
Enterprise Value$1.42T
Total Cash (Recent Filing)$233.43K
Total Debt (Recent Filing)$165.00K
Price to Earnings (P/E)―
Beta-2.24
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding850,165,340
10 Day Avg. Volume359,141
30 Day Avg. Volume163,995
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-0.12
Price to Sales (P/S)223.85
P/FCF Ratio-1.07
Enterprise Value/Market Cap760.09K
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-2.12M
Enterprise Value/Ebitda-1.21M
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Aibotics News
AIBT FAQ
What was Aibotics’s price range in the past 12 months?
Aibotics lowest stock price was <$0.01 and its highest was $0.14 in the past 12 months.
What is Aibotics’s market cap?
Aibotics’s market cap is $1.87M.
When is Aibotics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Aibotics’s earnings last quarter?
Currently, no data Available
Is Aibotics overvalued?
According to Wall Street analysts Aibotics’s price is currently Overvalued.
Does Aibotics pay dividends?
Aibotics does not currently pay dividends.
What is Aibotics’s EPS estimate?
Aibotics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Aibotics have?
Aibotics has 850,165,340 shares outstanding.
What happened to Aibotics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Aibotics?
Currently, no hedge funds are holding shares in AIBT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Aibotics
Aibotics Inc., together with its subsidiaries, engages in the study of psychedelics for the treatment of mental health issues in the United States. It provides psychedelic methodologies for the treatment of palliative care, depression, and anxiety. The company was formerly known as Mycotopia Therapies, Inc. and changed its name to Aibotics Inc. in February 2025 Aibotics Inc. is based in Miami, Florida.
Technical Analysis
Ownership Overview
13.97%
Insiders
―
Mutual Funds
― Other Institutional Investors
86.03% Public Companies and
Individual Investors